Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the AION group (people with a possible eye condition affecting the optic nerve):
- Doctors suspect you may have a newly developed loss of blood supply to the optic nerve (the nerve connecting your eye to your brain), based on symptoms in one eye such as swelling at the back of the eye, noticeable vision loss, or changes in how your pupil responds to light
- You are 50 years old or older
For the GCA group (people with a blood vessel inflammation condition called Giant Cell Arteritis):
- You have been recently diagnosed with Giant Cell Arteritis, confirmed by a doctor's examination and an ultrasound scan
- You do not currently have any vision changes in either eye related to Giant Cell Arteritis, such as temporary or permanent loss of vision, or temporary or permanent double vision
- You are 50 years old or older
Who may not be able to join:
- You have any metal implants in your body that are affected by magnets
- Your kidneys are not working well enough (confirmed by a specific blood test result) (confirm with trial site)
- You have a known allergy to the dye used in MRI scans
- You have severe fear of enclosed spaces (claustrophobia)
- You are currently pregnant or breastfeeding
- You have previously been diagnosed with a nerve condition in the same eye, or have a prior diagnosis of Giant Cell Arteritis
- You have already been taking a steroid medication called prednisolone for more than 5 days before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Orbital vascular inflammation on PET/MRI; Risk of vision loss in GCA; Retinal biomarkers in AION
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.